Signals, Powered By EquityPandit
Ajanta Pharma has posted a 3.41% increase in its consolidated net profit at Rs.147.47 crore for the December quarter. Last year, in the corresponding quarter it had reported a net profit of Rs.142.60 crore.
Consolidated revenue from operations also increased to Rs.587.05 crore for the quarter ended December 31,2017, while in the corresponding quarter last year it had reported consolidated revenue at Rs.533.11 crore.
Further, Yogesh Agrawal, Ajanta Pharma Managing Director stated, “We are pleased with our branded generic business performance in emerging markets which has posted healthy growth, in line with our expectation. Despite the challenging price erosion environment in the US market, we have performed well during the quarter.”
